ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 74 filers reported holding ADMA BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $90,000 | -10.0% | 22,500 | 0.0% | 0.01% | -15.4% |
| Q3 2019 | $100,000 | -40.5% | 22,500 | -39.9% | 0.01% | +30.0% |
| Q2 2018 | $168,000 | +64.7% | 37,460 | +68.7% | 0.01% | +42.9% |
| Q1 2018 | $102,000 | +161.5% | 22,200 | +107.5% | 0.01% | +250.0% |
| Q2 2017 | $39,000 | -57.1% | 10,700 | -43.0% | 0.00% | -66.7% |
| Q1 2017 | $91,000 | +33.8% | 18,787 | +40.4% | 0.01% | 0.0% |
| Q4 2016 | $68,000 | -75.9% | 13,380 | -65.7% | 0.01% | -73.9% |
| Q3 2016 | $282,000 | +51.6% | 39,000 | +24.6% | 0.02% | +35.3% |
| Q2 2016 | $186,000 | +67.6% | 31,300 | +126.8% | 0.02% | +54.5% |
| Q1 2016 | $111,000 | +26.1% | 13,800 | +25.5% | 0.01% | 0.0% |
| Q4 2015 | $88,000 | -14.6% | 11,000 | -1.8% | 0.01% | -21.4% |
| Q2 2015 | $103,000 | -21.4% | 11,200 | -18.8% | 0.01% | -22.2% |
| Q1 2015 | $131,000 | – | 13,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |